ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,188, issued on Sept. 9, was assigned to XIAMEN BIOTIME BIOTECHNOLOGY Co. LTD. (Xiamen, China).
"Adenosine receptor antagonist" was invented by Zhiyong Yu (Hangzhou, China), Shifeng Liu (Hangzhou, China) and Yongqiang Shi (Hangzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "A compound represented by formula (I) and a pharmaceutical composition thereof. The compound represented by formula (I) can be used as an adenosine receptor inhibitor, in particular, A2A and/or A2B inhibitors, for example, can be used for preventing or treating diseases related to A2A and/or A2B activity or expression level."
The patent was filed on July 29, 2020, und...